发明名称 Utilisation of neurotransmitter derivatives for manufacturing agents for treating neuroendocrinal diseases
摘要 Use of aminoacid precursor derivative of neurotransmitter for synthesis of neurotransmitter cofactor and neurotransmitter modulator and in the preparation of agent for the treatment of neuroendocrine health disorders, with stress hormone- and/or neurotransmitter imbalance control loop. An independent claim is included for a dietary supplement (DS1-DS8) comprising L-glutamine, L-tyrosine and L-histidine as essential component in DS1 (vitamin B5, vitamin C, vitamin B6, vitamin B3, vitamin B12, folic acid, magnesium, zinc, Rhodiola roseaand/or green tea extract as DS1A in addition to DS 1); theanine, 5-hydroxytryptophan and Mucuna pruriensas essential component in DS2 (vitaminB6, folic acid, vitamin B12, magnesium, Rhodiola rosea, taurin and/or phospatidylcholine as DS2A); L-tyrosine and Mucuna pruriensas essential component in DS3 (vitamin C, vitamin B6, folic acid, calcium, selenium and/or N-acetyl cystein as DS3A); L-tyrosine, L-histidine and Mucuna pruriensas essential component in DS4 (vitamin C, vitamin B5, vitamin B6, vitamin B3, folic acid, magnesium, zinc, manganese, N-acetyl-cystein and/or Rhodiola roseaas DS4A); L-glutamine, theanine, 5-hydroxytryptophan and L-tyrosine as essential component in DS5 (vitamin C, vitamin B6, folic acid, magnesium, taurine and/or tocopherol/tocotrienol as DS5A); Mucuna pruriensand 5-hydroxytryptophan as essential component in DS6 (vitamin B3, vitamin B5, vitamin B6, folic acid, vitamin B12, zinc, chromium, selenium, manganese, N-acetyl cystein and/or green tea extract as DS6A); L-tyrosine, 5-hydroxytryptophan and theanine as essential component in DS7 (vitamin C, vitamin B6, folic acid, calcium and/or L-phenylalanine as DS7A); and 5-hydroxytryptophan and theanine as essential component in DS8 (vitamin C, vitamin B6, folic acid, vitamin B12, magnesium, zinc, selenium, taurine and/or N-acetyl-cystein as DS8A). ACTIVITY : Nootropic; Tranquilizer; Muscular-Gen; Immunomodulator; Analgesic; Antimigraine; Anorectic; Antidepressant; Hypnotic; Gynecological; Gastrointestinal-Gen; Endocrine-Gen. MECHANISM OF ACTION : None given.
申请公布号 EP1854486(A2) 申请公布日期 2007.11.14
申请号 EP20070104021 申请日期 2007.03.13
申请人 BIEGER, WILFRIED P. 发明人 BIEGER, WILFRIED P.
分类号 A61K45/06;A23L1/302;A23L1/304;A23L1/305;A61K31/185;A61K31/197;A61K31/198;A61K31/355;A61K31/375;A61K31/405;A61K31/4172;A61K31/4415;A61K31/445;A61K31/685;A61K31/714;A61K33/04;A61K33/06;A61K33/24;A61K33/30;A61K33/32;A61K36/41;A61K36/48;A61K36/82;A61P25/00 主分类号 A61K45/06
代理机构 代理人
主权项
地址